SYSTEMIC LUPUS ERYTHEMATOSUS TREATMENT MARKET ANALYSIS

Systemic Lupus Erythematosus Treatment Market, by Treatment Type (Antimalarial Drugs, Non-Steroidal Anti-Inflammatory Drugs, Cytotoxic and Immunosuppressive Drugs, and Biologics), By Route of Administration (Intravenous, Sub-cutaneous, Oral, and Topical), By Distribution Channel (Retail Pharmacy and Online Pharmacy) and by Geography - Global Industry Insights, Trends, Outlook and Opportunity Analysis, 2022-2028

To Be Published : Dec 2024
Code : CMI1540
Formats :
Excel and PDF
Industry : Pharmaceutical

Market Challenges And Opportunities

However, cost associated with the treatment of systemic lupus erythematosus is high, which makes the treatment unaffordable. Biological drugs are covered under Medi Claim, however, unfavorable reimbursement scenario for new drugs and biologics may limit adoption of these drugs, which is expected to adversely affect the market growth.